The Types of VWD
Last updated:
Von Willebrand Disease (VWD) is a spectrum of clotting disorders categorized by the type of defect in the von Willebrand factor protein. Type 1 is a partial shortage, Type 3 is a complete absence, and Type 2 variants involve functional issues like inability to bind Factor VIII or excessive stickiness.
Key Takeaways
- • Type 1 VWD is a partial protein deficiency and is the most common form, typically inherited in a dominant pattern.
- • Type 2N VWD mimics Hemophilia A because the protein fails to bind and protect Factor VIII.
- • Type 3 VWD is a severe total absence of von Willebrand factor and usually requires inheriting the gene from both parents.
- • Type 2B VWD involves a gain-of-function mutation where the protein is too sticky, often causing low platelet counts.
Every diagnosis of Von Willebrand Disease (VWD) is unique because the genetics of the disorder are complex and “layered.” While we categorize the disease into types, it is more accurate to think of it as a spectrum of how your body’s “clotting glue” functions [1][2].
Type 1: The Spectrum of “Not Enough”
Type 1 is a partial quantitative deficiency, meaning your body makes the right kind of VWF, but not in high enough amounts [3][4].
- Not Always “Mild”: While Type 1 is often called “mild,” this can be misleading [1]. Some people with Type 1 experience significant bleeding, such as a 15% risk of delayed postpartum hemorrhage compared to only 1% in the general population [5][6]. Your bleeding score (how many symptoms you have) is often a better predictor of your risk than your actual lab numbers [7][8].
- Inheritance: Type 1 is typically autosomal dominant [3]. This means you only need one copy of the changed gene (from one parent) to have the condition, and there is a 50% chance of passing it to your children [3][4].
Type 2N: The “Broken Seatbelt” Analogy
Type 2N is a specialized qualitative defect where your VWF “glue” works perfectly for platelets, but it has a specific problem with its “passenger,” Factor VIII [9][10].
- The Analogy: Imagine VWF is a car with a seatbelt designed to hold Factor VIII safely in place [11][12]. In Type 2N, that “seatbelt” is broken. Factor VIII sits in the car, but because it isn’t buckled in, it falls out and is destroyed by the body [10][13].
- The Result: Because the “passenger” (Factor VIII) is lost, your blood levels look almost exactly like Hemophilia A [9][14].
- Inheritance: Unlike Type 1, Type 2N is usually recessive, meaning you typically need to inherit two copies of the changed gene (one from each parent) to show symptoms [13].
Type 3: The Complete Absence
Type 3 is a total quantitative deficiency [15]. Your body makes virtually no VWF “glue” at all [16].
- Inheritance: This is also autosomal recessive [15][17]. Most people with Type 3 have parents who are “carriers” (they have one gene each). These carriers might have slightly low VWF levels (like Type 1) or no symptoms at all [15].
Type 2B: The “Too Sticky” Glue
Type 2B is a rare gain-of-function mutation [18].
- The Problem: Your VWF is too good at its job. It grabs onto platelets while they are still floating in your bloodstream, rather than waiting for an injury [18]. This creates clumps that the body then clears out, leading to a low platelet count (thrombocytopenia) [18].
Summary Table: Inheritance at a Glance
| VWD Type | Deficiency Type | Usual Inheritance | Chance to Pass to Child |
|---|---|---|---|
| Type 1 | Partial Quantity | Dominant | 50% |
| Type 2A, B, M | Quality | Usually Dominant | 50% |
| Type 2N | FVIII Binding | Recessive | Very Low* |
| Type 3 | Total Absence | Recessive | Very Low* |
*Unless the other parent is also a carrier. [3][4][15][17]
Knowing your type and how it was inherited can help your family members get the testing they may need [19].
Frequently Asked Questions
What is the difference between Type 1 and Type 3 VWD?
Why is Type 2N VWD sometimes confused with Hemophilia A?
Is Von Willebrand Disease passed down from parents?
What makes Type 2B VWD different from other types?
Questions for Your Doctor
- • My diagnosis is 'Type 1'—could you help me understand where I fall on the spectrum of symptoms, and what my specific bleeding score (ISTH-BAT) is?
- • Since Type 1 is often 'autosomal dominant,' what are the chances that my children will inherit this condition?
- • If I have Type 2N, are there specific genetic tests we can use to confirm the 'broken seatbelt' binding defect?
- • If I carry one copy of the gene for Type 3, am I considered a 'carrier,' and do carriers ever experience bleeding symptoms?
- • How does the 'gain of function' in Type 2B affect my platelet count, and should we monitor it during times of stress?
Questions for You
- • Do you have a parent or sibling with a similar bleeding history? Most VWD types are 'dominant,' meaning they are passed directly from one generation to the next.
- • Has anyone in your family ever been diagnosed with Hemophilia A? This can sometimes be a clue for Type 2N VWD.
- • If you have Type 1, have you noticed that your symptoms are consistent, or do they seem to change over time or with age?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Low von Willebrand factor-unraveling an enigma wrapped in a conundrum.
O'Donnell JS, Baker RI, Atiq F
Journal of thrombosis and haemostasis : JTH 2024; (22(12)):3383-3388 doi:10.1016/j.jtha.2024.08.015.
PMID: 39265913 - 2
How I treat von Willebrand disease.
Castaman G
Thrombosis research 2020; (196()):618-625 doi:10.1016/j.thromres.2020.07.051.
PMID: 32819724 - 3
How much do we really know about von Willebrand disease?
Swystun LL, Lillicrap D
Current opinion in hematology 2016; (23(5)):471-8 doi:10.1097/MOH.0000000000000272.
PMID: 27428891 - 4
How we make an accurate diagnosis of von Willebrand disease.
Baronciani L, Peyvandi F
Thrombosis research 2020; (196()):579-589 doi:10.1016/j.thromres.2019.07.010.
PMID: 31353031 - 5
Postpartum Hemorrhage in Patients with Type 1 von Willebrand Disease: A Systematic Review.
Pierce-Williams RAM, Makhamreh MM, Blakey-Cheung S, et al.
Seminars in thrombosis and hemostasis 2022; (48(2)):219-228 doi:10.1055/s-0041-1736572.
PMID: 34749402 - 6
Procedural outcomes in children with mild type 1 von Willebrand disease.
Heery S, Zimowski K, Mason SF, et al.
Research and practice in thrombosis and haemostasis 2024; (8(1)):102334 doi:10.1016/j.rpth.2024.102334.
PMID: 38440264 - 7
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Flood VH, Christopherson PA, Gill JC, et al.
Blood 2016; (127(20)):2481-8 doi:10.1182/blood-2015-10-673681.
PMID: 26862110 - 8
Bleeding score in type 1 von Willebrand disease patients using the condensed MCMDM-1 vWD validated questionnaire.
Pathare A, Al Hajri F, Al Omrani S, et al.
International journal of laboratory hematology 2018; (40(5)):515-520 doi:10.1111/ijlh.12850.
PMID: 29754468 - 9
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL, Georgescu I, Mewburn J, et al.
Journal of thrombosis and haemostasis : JTH 2017; (15(8)):1607-1619 doi:10.1111/jth.13749.
PMID: 28581694 - 10
Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
Favaloro EJ, Mohammed S, Vong R, Pasalic L
Methods in molecular biology (Clifton, N.J.) 2023; (2663()):679-691 doi:10.1007/978-1-0716-3175-1_45.
PMID: 37204745 - 11
Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.
Kiouptsi K, Reinhardt C
Sub-cellular biochemistry 2020; (94()):437-464 doi:10.1007/978-3-030-41769-7_18.
PMID: 32189311 - 12
Laboratory monitoring of replacement therapy for major surgery in von Willebrand disease.
Mannucci PM, Franchini M
Haemophilia : the official journal of the World Federation of Hemophilia 2017; (23(2)):182-187 doi:10.1111/hae.13165.
PMID: 28111840 - 13
Von Willebrand disease type 2N: An update.
Seidizadeh O, Peyvandi F, Mannucci PM
Journal of thrombosis and haemostasis : JTH 2021; (19(4)):909-916 doi:10.1111/jth.15247.
PMID: 33497541 - 14
Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype.
van Meegeren ME, Mancini TL, Schoormans SC, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2015; (21(5)):e375-83 doi:10.1111/hae.12733.
PMID: 26207643 - 15
A Novel Case of Compound Heterozygous Type 3 Von Willebrand Disease.
Mandava M, Bergmann S, Lazarchick J
Annals of clinical and laboratory science 2019; (49(3)):393-394.
PMID: 31308041 - 16
Health-Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL-QoL Study.
von Mackensen S, Moorthi C, Fischer R, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2025; doi:10.1111/hae.70073.
PMID: 41313635 - 17
Rare forms of von Willebrand disease.
Favaloro EJ
Annals of translational medicine 2018; (6(17)):345 doi:10.21037/atm.2018.09.10.
PMID: 30306084 - 18
von Willebrand disease.
Seidizadeh O, Eikenboom JCJ, Denis CV, et al.
Nature reviews. Disease primers 2024; (10(1)):51 doi:10.1038/s41572-024-00536-8.
PMID: 39054329 - 19
Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives.
Favaloro EJ, Pasalic L
Seminars in thrombosis and hemostasis 2022; (48(6)):750-766 doi:10.1055/s-0042-1754331.
PMID: 36055264
This guide explains the classification of Von Willebrand Disease types for educational purposes. A hematologist must perform specific blood and genetic tests to confirm your diagnosis and determine your type.
Stay up to date
Get notified when new research about Von Willebrand Disease is published.
No spam. Unsubscribe anytime.